- Home
- CDRE vs PAHC Comparison
CDRE vs PAHC Comparison
Compare CDRE & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDRE
- PAHC
- Stock Information
- Founded
- CDRE 2012
- PAHC 1946
- Country
- CDRE United States
- PAHC United States
- Employees
- CDRE N/A
- PAHC N/A
- Industry
- CDRE Industrial Specialties
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- CDRE Health Care
- PAHC Health Care
- Exchange
- CDRE Nasdaq
- PAHC Nasdaq
- Market Cap
- CDRE N/A
- PAHC 746.5M
- IPO Year
- CDRE 2021
- PAHC 2014
- Fundamental
- Price
- CDRE $36.48
- PAHC $22.25
- Analyst Decision
- CDRE Strong Buy
- PAHC Sell
- Analyst Count
- CDRE 1
- PAHC 4
- Target Price
- CDRE $37.00
- PAHC $20.00
- AVG Volume (30 Days)
- CDRE 331.4K
- PAHC 219.6K
- Earning Date
- CDRE 05-06-2025
- PAHC 05-07-2025
- Dividend Yield
- CDRE 1.04%
- PAHC 2.15%
- EPS Growth
- CDRE N/A
- PAHC 140.15
- EPS
- CDRE 0.95
- PAHC 0.78
- Revenue
- CDRE $559,807,000.00
- PAHC $1,190,682,000.00
- Revenue This Year
- CDRE $8.19
- PAHC $27.84
- Revenue Next Year
- CDRE $8.18
- PAHC $10.22
- P/E Ratio
- CDRE $38.53
- PAHC $28.64
- Revenue Growth
- CDRE 10.06
- PAHC 19.12
- 52 Week Low
- CDRE $27.07
- PAHC $16.06
- 52 Week High
- CDRE $40.28
- PAHC $26.55
- Technical
- Relative Strength Index (RSI)
- CDRE 75.01
- PAHC 67.99
- Support Level
- CDRE $28.95
- PAHC $18.89
- Resistance Level
- CDRE $31.04
- PAHC $19.65
- Average True Range (ATR)
- CDRE 1.58
- PAHC 0.82
- MACD
- CDRE 0.74
- PAHC 0.52
- Stochastic Oscillator
- CDRE 91.62
- PAHC 97.60
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.